Sponsor: QiagenIn this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.
Single-Cell Functional Proteomics Accelerates Immunotherapy Development Opportunities from Pre-Clinical to Clinical Stages
Sponsor: IsoPlexisIsoPlexis’ next generation systems provide actionable potency, safety, and patient difference metrics by detecting highly potent single cell functional subsets for the first time.
Sponsor: ThermoFisher Scientific REGISTER NOW Broadcast Date: October 1, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Accurate monitoring of cell signaling pathway proteins, particularly tyrosine phosphorylation (pTyr)...
Sponsor: Qiagen REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Sponsor: ThermoFisher Scientific VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...
Sponsor: Molecular MDCodevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.
Sponsor: Bio-RadIn this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.
Sponsor: ThermoFisher ScientificLarge cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.
Sponsor: ThermoFisher ScientificCoupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".
Sponsor: MolecularMDIn this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.